Date | Company Name | Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|---|
Mar 8, 2022 | DNAnexus | Series H | — | Bioinformatics | — |
Jan 6, 2022 | Eikon Therapeutics | Series B | — | Biotechnology | — |
Sep 9, 2021 | Mammoth Biosciences | Series D | — | Biotechnology | — |
Jun 29, 2021 | Element Biosciences | Series C | — | Biotechnology | — |
Jun 28, 2021 | HealthVerity | Series D | — | Health Care | — |
May 11, 2021 | Aetion | Series C | — | Analytics | — |
May 5, 2021 | Eikon Therapeutics | Series A | — | Biotechnology | — |
Nov 25, 2020 | SomaLogic | Series A | — | Biotechnology | — |
Nov 4, 2020 | Mammoth Biosciences | Series C | — | Biotechnology | Yes |
Jun 10, 2020 | Cue | Series C | — | Health Care | — |
Jun 9, 2020 | DNAnexus | Series G | — | Bioinformatics | — |
Jan 11, 2020 | PACT Pharma | Series C | — | Biotechnology | — |
Jan 9, 2020 | Element Biosciences | Series B | — | Biotechnology | — |
Nov 21, 2019 | Genapsys | Series C | — | Bioinformatics | Yes |
Aug 9, 2019 | ORIC Pharmaceuticals | Series D | — | Biotechnology | — |
Jun 18, 2019 | Element Biosciences | Series A | — | Biotechnology | Yes |
Apr 3, 2019 | HealthVerity | Series C | — | Health Care | Yes |
Feb 6, 2019 | DNAnexus | Series F | — | Bioinformatics | — |
Feb 21, 2018 | ORIC Pharmaceuticals | Series C | — | Biotechnology | — |
Jan 2, 2018 | DNAnexus | Series E | — | Bioinformatics | Yes |
Nov 13, 2017 | Arcus Biosciences | Series C | — | Biotechnology | — |
Sep 8, 2017 | Replimune Group | Series B | — | Biotechnology | Yes |
Sep 1, 2016 | Arcus Biosciences | Series B | — | Biotechnology | — |
Feb 17, 2016 | 10X Genomics | Series C | — | Biotechnology | — |
Jan 19, 2016 | Twist Bioscience | Series D | — | Biotechnology | — |
Dec 2, 2015 | ORIC Pharmaceuticals | Series B | — | Biotechnology | — |
Sep 1, 2015 | Intellia Therapeutics | Series B | — | Biotechnology | — |
Jun 22, 2015 | Ardelyx | Post-IPO Equity | — | Biotechnology | — |
Jun 9, 2015 | Twist Bioscience | Series C | — | Biotechnology | — |
Dec 12, 2014 | 10X Genomics | Series B | — | Biotechnology | Yes |
Jul 31, 2013 | Karyopharm Therapeutics | Series B | — | Health Care | Yes |